Log in

Relevant bibliographies by topics / Masaryk Institute of Oncology / Journal articles

To see the other types of publications on this topic, follow the link: Masaryk Institute of Oncology.

Journal articles on the topic 'Masaryk Institute of Oncology'

Author: Grafiati

Published: 28 June 2021

Last updated: 17 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Masaryk Institute of Oncology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Macháčková, Eva, Jana Házová, Eva Sťahlová Hrabincová, Petra Vašíčková, Marie Navrátilová, Marek Svoboda, and Lenka Foretová. "Retrospective NGS Study in High-risk Hereditary Cancer Patients at Masaryk Memorial Cancer Institute." Klinicka onkologie 29, Suppl 1 (January 15, 2016): S35—S45. http://dx.doi.org/10.14735/amko2016s35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pešová, Zdeňka, Monika Náležinská, Marie Dvořáková, Jana Kocurková, and Josef Chovanec. "Ostacles of the daily care of patients with permanent urine catether following radical gynae-oncological surgical procedure in Masaryk Memorial Cancer Institute, Brno, Czech Republic." Onkologie 14, no. 2 (June 2, 2020): 100–102. http://dx.doi.org/10.36290/xon.2020.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Grell, Peter, Vit Kandrnal, Bortlicek Zbynek, and Rostislav Vyzula. "Lapatinib efficacy according to metastatic sites in trastuzumab pretreated patients with HER2-positive metastatic breast cancer: An analysis form IntERB registry in the Czech Republic." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e11072-e11072. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e11072.

Full text

Abstract:

e11072 Background: Lapatinib is an oral dual tyrosin kinase inhibitor of EGFR and HER2 and compared to trastuzumab penetrates to CNS. We evaluated efficacy and safety of lapatinib treatment according to different metastatic sites involvement using data from IntERB registry that has been initiated and run by Czech Society for Oncology and Institute of Biostatistics and Analyses at Masaryk University, Brno, Czech Republic. Methods: An analysis included 213 patients with HER2 positive metastatic breast cancer treated from January 2007 to September 2011. Lapatinib was mostly administered orally 1250mg/day with capecitabine (2000mg/m2 D1-14), 16 patients received lapatinib in monotherapy. All patients had experienced progression during prior trastuzumab based therapy. Results: Median age was 56 years (range 23 – 78). Median duration of lapatinib therapy was 20.6 weeks (range 1–146). Complete response was achieved in 13 patients (6.1%), partial response in 31 (14.6%), stable disease in 118 (55.4%). In 26 disease have progressed (12.2%); response could not be assessed in 25 patients (11.7%). PFS for whole group was 7.1 months (95% CI 5.9-8.5). Overall survival was 17.2m (95% CI 15.8-18.6), probability of 6m OS was 80.3% and 1-year OS was 64%. Metastatic sites specific survival was evaluated in 103 patients. CNS dissemination was initially diagnosed in 31 patients (30.1%), PFS in this group was 6.2m (95% CI 3.3-9.1), OS was not reached, 6-m OS was 67.3%. In non-CNS group (skeletal metastasis in 49.5%, lung 38.8%, hepatic 36.9%, lymphatic 17.5%, other 15.5%) was PFS 6.3m (95% CI 1.6-11.1), OS 22.0m (95% CI 15.3-28.8) and 6-m OS was 88.2%. Most common toxicities were diarrhea in 11.7% patients, rash/skin toxicity in 10.8%, nausea/vomitus in 5.2% and hepatotoxicity in 2.3%. No cardiac toxicity was reported. Therapy was discontinued due toxicity in 9.0%. Conclusions: Lapatinib in combination with capecitabine proved its efficacy in trastuzumab pretreated HER2 positive metastatic breast cancer. Even in patients with CNS involvement was achieved a notable PFS and OS, comparable to non-CNS group of patients. Therapy was well tolerated.

APA, Harvard, Vancouver, ISO, and other styles

4

Hasnikova, Hana, and Petr Kuklík. "Investigation of Timber Members at the Marasyk Station in Prague by Non-Destructive Methods." Advanced Materials Research 778 (September 2013): 243–49. http://dx.doi.org/10.4028/www.scientific.net/amr.778.243.

Full text

Abstract:

The Masaryk Railway Station is the oldest still working terminal railway station in Europe. It was built in 1845 and the buildings belonged to the most splendid railway stations in that time. During the long life the part of Masaryk Station burned, it was also damaged while World Wars and finally large reconstruction started last year. The buildings have a high historical value, so the specialists from National Heritage Institute wanted all the original structural members to be preserved. The structure was constructed from two wooden species spruce and fir. Selected timber elements were tested by various non-destructive methods to assess their health. Pilodyn, a device with iron stick can assess a material quality using correlation between depth of stick indentation and material strength. Sylvatest device operates with ultrasonic waves and can determine dynamic modulus of elasticity as one of the mechanical characteristics. Dynamoe device uses an acoustic wave to assess the material quality. The aim of the paper is to present the procedure of timber testing and to discuss measured results.

APA, Harvard, Vancouver, ISO, and other styles

5

Mlejnková, Hana, and Zdenka Žáková. "Use of microbiological and biological methods for monitoring the influence of diffuse pollution on reservoir's water quality." Water Science and Technology 33, no. 4-5 (February 1, 1996): 341–47. http://dx.doi.org/10.2166/wst.1996.0524.

Full text

Abstract:

The research results of water supply reservoirs and their tributaries in the Morava River basin showed the important role of the biological and microbiological investigations by monitoring the influence of diffuse pollution on the reservoir's water quality. Our report brings the critical evaluation of the possibility to use some microbiological and biological methods by monitoring of diffuse pollution, it also includes some practical results received from monitoring the streams and reservoirs within the Morava River basin (in the frame of research projects of the T. G. Masaryk Water Research Institute, branch office Brno).

APA, Harvard, Vancouver, ISO, and other styles

6

Hauner, Milan. "Dagmar Hájková, and Šedivý Ivan, eds. Korespondence T.G. Masaryk—Edvard Beneš, 1914–1918. Prague: Masaryk Institute of the Academy of Sciences of the Czech Republic, 2004. Pp. 353." Austrian History Yearbook 37 (January 2006): 234–35. http://dx.doi.org/10.1017/s0067237800017008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Montel, Christopher. "Role amerických a francouzských spolupracovníků v mezinárodní strategii redakčního týmu Sociologické revue ve 30. letech." Sociální studia / Social Studies 17, no. 2020 SPEC (December 18, 2020): 53–68. http://dx.doi.org/10.5817/soc2020-s-53.

Full text

Abstract:

Three French sociologists (Bouglé, Duprat and Richard), as well as three sociologists from the United States (Hasek, Rouček and Sorokin), exclusively represented Western sociology in a list of nine foreign collaborators, which featured from 1933 to 1940 on the first page of the Czech periodical Sociologická revue. Duprat and Richard were evidently included in this list at a time when the Masaryk Sociological Society, whose publishing organ was the Sociologická revue, played a significant role in the resumed activities of the International Institute of Sociology. The collaboration of the three “American” sociologists was more participative. It answered the urgent need, according to the revue’s redacting team, to inform readers on the latest developments in the field from America. The names of Bouglé, and above all Sorokin, undoubtedly represented in this list a symbolic advantage for the revue’s redacting team and its international strategy.

APA, Harvard, Vancouver, ISO, and other styles

8

McNamee, David. "European Institute of Oncology opens." Lancet 343, no. 8910 (June 1994): 1424. http://dx.doi.org/10.1016/s0140-6736(94)92545-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Topuz, Erkan, and Inci Ayan. "University of Istanbul, Institute of Oncology." Pediatric Hematology and Oncology 14, no. 4 (January 1997): 315–21. http://dx.doi.org/10.3109/08880019709041591.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mełgieś, Katarzyna. "CURRENT HEALTH LAW ISSUES IN CENTRAL AND EASTERN EUROPE(LUBLIN, 3 JUNE 2016, CONFERENCE REPORT)." Review of European and Comparative Law 2627, no. 34 (December 31, 2019): 225–29. http://dx.doi.org/10.31743/recl.5077.

Full text

Abstract:

On 3 June 2016 an international conference on Current Health Law Issues in Central and Eastern Europe took place at the John Paul II Catholic University of Lublin. The conference was organised by the Department of Administrative Law at the Faculty of Law, Canon Law and Administra-tion under the honorary patronage of the European Association of Health Law (EAHL). The aim of the above-mentioned meeting was to create the platform for exchange of experiences and sharing views by researches and experts from the field of health law from post-communist countries where transformation processes caused many changes in the health system, also in the perspective of their EU memberships. The foreign research centres represented at the conference were the Masaryk University in Brno from the Czech Republic, the National Academy of Management in Kiev and the Legislation Institute of Verkhovna Rada of Ukraine from Ukraine, the University of Ljubljana from Slovenia, and the Kauno Kolegija University of Applied Sciences from Lithuania. Polish speakers and other participants derived, among others, from the Medical University of Lublin, the Jagiel-lonian University, the University of Rzeszów and the John Paul II Catholic University of Lublin.

APA, Harvard, Vancouver, ISO, and other styles

11

Balvín, Pavel, Adam Vizina, Magdalena Nesládková, Johanna Blöcher, Marcela Makovcová, Vojtěch Moravec, and Martin Hanel. "Minimum Residual Flows for Catchments in the Czech Republic." Water 13, no. 5 (March 3, 2021): 689. http://dx.doi.org/10.3390/w13050689.

Full text

Abstract:

The determination of minimum residual flow (MRF) follows diverse methodology in Europe due to differing hydrological conditions, ecosystem requirements, water abstraction requirements, and legislation. Methodologies in individual countries are difficult to compare qualitatively. However, individual approaches can serve as examples for countries undergoing the process of developing new methodologies, either for legislative purposes or to improve environmental standards on watercourses. This is exactly the situation in the Czech Republic which, has been working on the Regulation of the Government of the Czech Republic for ten years, since the amendment to the Water Act in 2010, defines the methods and criteria for determining the MRF on watercourses. T.G. Masaryk Water Research Institute, p.r.i., was commissioned to develop a new methodology to serve as the basis for the wording of aforementioned regulation. The new methodological approach took into account modern trends concerning the preservation of ecological standards, and used standard hydrological characteristics for its calculations. The newly proposed approach is undergoing a complicated approval process as the authors seek to increase the MRF compared to the current approach. The new approach assumes an MRF setting between Q97 and Q90. It defines four areas within the Czech Republic, by their hydrological and hydrogeological conditions, where the MRF is determined in different ways. This article describes the development of a new methodological approach, including the use the available Czech Hydrometeorological Institute data sets, the proposed regional division for MRF calculations, the determination the MRF below reservoirs, and the current state of the issue.

APA, Harvard, Vancouver, ISO, and other styles

12

Veronesi, Umberto. "The European Institute of Oncology in Milan." Breast Care 1, no. 3 (2006): 168–69. http://dx.doi.org/10.1159/000093321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Vanchieri, C. "European Institute of Oncology Inaugurated in Milan." JNCI Journal of the National Cancer Institute 86, no. 11 (June 1, 1994): 827. http://dx.doi.org/10.1093/jnci/86.11.827.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Zelenková, Anna. "Folklorist and Ethnological Research Supported by the Board for the Research of Slovakia and Subcarpathian Ruthenia in Prague during the Interwar Period." Slovenský národopis / Slovak Ethnology 68, no. 1 (March 1, 2020): 84–98. http://dx.doi.org/10.2478/se-2020-0005.

Full text

Abstract:

AbstractThe paper focuses on selected folklorist and ethnological activities during the inter-war period, financially supported by the Board for the Research of Slovakia and Subcarpathian Ruthenia, which was established on the initiative of T. G. Masaryk as part of the newly created Slavic Institute in Prague in 1928. This institution aimed to support links between Slovakia and the so-called Czech historical lands and the expressions of “mutuality” in the scientific, cultural or ethnic and language area, etc. The Board provided grants for conducting dialectological, folklorist, geographical and other projects, e.g. for the collection initiative of F. Wollman and his students in Bratislava and Brno in 1928–1947, covering Slovak and (yet unprocessed) Moravian folk fiction. Support was also granted to the research of music culture (D. Orel, K. Hudec, F. Zagriba, etc.), the collection of anthropological and ethnographical materials (K. Chotek, K. Domin, etc.), the study of Slovak folk embroidery (V. Pražák), folklore customs and practices (P. Bogatyrev), folk wood architecture (V. Sičynskyj, D. Stránská), Slovak dialects studied, for example, by V. Vážný, member of the Board, etc. The Slovak Encyclopaedia project, today already forgotten, was not completed. Its editors included historian V. Chaloupecký and, in particular, K. Chotek who prepared the concept of the work in 1930.

APA, Harvard, Vancouver, ISO, and other styles

15

MCKEARNEY, J. W. "National Cancer Institute Response." JNCI Journal of the National Cancer Institute 87, no. 23 (December 6, 1995): 1806–7. http://dx.doi.org/10.1093/jnci/87.23.1806-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Saghatchian, Mahasti, and Thomas Tursz. "Organisation of European Cancer Institute says…" Lancet Oncology 4, no. 12 (December 2003): 718. http://dx.doi.org/10.1016/s1470-2045(05)70061-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Bulski, Wojciech, Barbara Gwiazdowska, and Jerzy Tołwiński. "Radium Institute in Warsaw – the ancestor of the Institute of Oncology: The radium era." Analytical and Bioanalytical Chemistry 400, no. 6 (April 13, 2011): 1587–92. http://dx.doi.org/10.1007/s00216-011-4900-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Hassan, E., S. Afqir, N. Ismaili, H. M’rabti, S. Boutayeb, and I. Elghissassi. "Nasopharyngeal carcinoma at the National Institute of Oncology." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e17055-e17055. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e17055.

Full text

Abstract:

e17055 Background: To evaluate the disease characteristics and outcome of patients with nasopharyngeal carcinoma treated at the National Institute of Oncology (NIO) Rabat, Morocco. Methods: Between 1999 and 2001, 468 patients with a diagnosis of nasopharyngeal carcinoma were treated at the NIO. The median age was 42 years (range 10 to 83). The male/female ratio was 2.5/1. Of the 468 patients, 88 (19%), and 380 (81%) had T1-T2, and T3- T4 (TNM International Union Against Cancer staging system, 1997), respectively. Ninety percent presented with nodal metastasis. 163 patients (35%) had lymph nodes >6 cm, and 229 (49%) had bilateral nodes at presentation. Histologically, 405 patients (86%) had undifferentiated carcinoma. Seventy-six percent received neoadjuvant multiagent chemotherapy containing cisplatin, followed by radiotherapy (RT). Results: After a median follow-up of 26 months, the disease-free survival (DFS) and overall survival (OS) rate for the entire group was 27% and 41%, respectively. Kaplan-Meier curves were used for evaluation of prognostic factors and were compared using the log-rank test. Nodal status had a significant impact on OS (p < 0.001). Complete responders to chemotherapy had superior DFS and OS. Conclusions: Combined modality management using chemotherapy and RT resulted in satisfactory locoregional control and OS in patients with nasopharyngeal carcinoma. Nodal involvement and response to chemotherapy were important prognostic factors. No significant financial relationships to disclose.

APA, Harvard, Vancouver, ISO, and other styles

19

Arush, Myriam Weyl Ben, Monique Peretz Nahum, Jehuda-Adi Bar Maor, Janet Dale, and Abraham Kuten. "Wilmss' tumor: The northern israel oncology institute experience." Journal of Surgical Oncology 59, no. 1 (May 1995): 10–13. http://dx.doi.org/10.1002/jso.2930590104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Raina, V., A. Gogia, SVS Deo, NK Shukla, and BK Mohanti. "Male breast cancer: A single institute experience." Indian Journal of Cancer 52, no. 4 (2015): 526. http://dx.doi.org/10.4103/0019-509x.178399.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Niederhuber, John. "Institute of Medicine (IOM) Workshop." Oncologist 16, no. 12 (November 29, 2011): 1665–66. http://dx.doi.org/10.1634/theoncologist.2011-0388.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Margossian, Astrid L., Gustavo Jankilevich, Ruth Weinberg, Eduardo Gallo, and Juan Margossian. "Breast Center Institute Buenos Aires, Argentina." Breast Care 2, no. 4 (2007): 257–58. http://dx.doi.org/10.1159/000105561.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Dou, Paige. "Reviewer Acknowledgements for Review of European Studies, Vol. 12, No. 1." Review of European Studies 12, no. 1 (March 2, 2020): 106. http://dx.doi.org/10.5539/res.v12n1p106.

Full text

Abstract:

Review of European Studies wishes to acknowledge the following individuals for their assistance with peer review of manuscripts for this issue. Their help and contributions in maintaining the quality of the journal are greatly appreciated. Review of European Studies is recruiting reviewers for the journal. If you are interested in becoming a reviewer, we welcome you to join us. Please find the application form and details at http://recruitment.ccsenet.org and e-mail the completed application form to res@ccsenet.org. Reviewers for Volume 12, Number 1 Alejandra Moreno Alvarez, Universidad de Oviedo, Spain Antonio Messeni Petruzzelli, Politecnico di Bari, Italy Arthur Becker-Weidman, Center For Family Development, USA Aziollah Arbabisarjou, Zahedan University of Medical Sciences, Iran Eugenia Panitsides, University of Macedonia, Greece Federico De Andreis, University Giustino Fortunato, Italy Florin Ionita, The Bucharest Academy of Economic Studies, Romania Frantisek Svoboda, Masaryk University, Czech republic Gabriela Gruber, Lucian Blaga University of Sibiu, Romania Gevisa La Rocca, University of Enna “Kore”, Italy Ghaiath M. A. Hussein, University of Birmingham, UK Gülce Başer, Boğaziçi University, Tukey Ifigeneia Vamvakidou, University of Western Macedonia, Greece Indrajit Goswami, N. L. Dalmia Institute of Management Studies and Research, India Ioan-Gheorghe Rotaru, ‘Timotheus’ Brethren Theological Institute of Bucharest, Romania Julia Stefanova, Economic Research Institute – The Bulgarian Academy of Sciences, Bulgaria Karen Ferreira-Meyers, University of Swaziland, Swaziland Maria Pescaru, University of Pitești, ROMANIA Montserrat Crespi Vallbona, University of Barcelona, Spain Muhammad Saud, Universitas Airlangga, Indonesia Natalija Vrecer, independent researcher, Slovenia Nunzia Di Cristo Bertali, Liverpool John Moores University, United Kingdom Serdar Yilmaz, World Bank, USA Skaidrė Žičkienė, &Scaron;iauliai University, Lithuania Szabolcs Blazsek, Universidad Francisco Marroquin, Guatemala Tryfon Korontzis, Hellenic National School of Local Government, Greece Valeria Vannoni, University of Perugia, Italy Vicenta Gisbert, Universidad de La Laguna, Spain

APA, Harvard, Vancouver, ISO, and other styles

24

Furlow, Bryant. "US Institute of Medicine studies military burn pits." Lancet Oncology 11, no. 4 (April 2010): 316. http://dx.doi.org/10.1016/s1470-2045(10)70078-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Steimle, Sabine. "French Government Launches National Cancer Institute." JNCI: Journal of the National Cancer Institute 97, no. 15 (August 3, 2005): 1116–17. http://dx.doi.org/10.1093/jnci/dji262.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Necheles, Thomas F. "Opening remarks—national cancer institute pespective." Cancer 56, S7 (October 1, 1985): 1745. http://dx.doi.org/10.1002/1097-0142(19851001)56:7+<1745::aid-cncr2820561303>3.0.co;2-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Printz, Carrie. "National Cancer Institute to merge programs." Cancer 118, no. 22 (November 5, 2012): 5451–52. http://dx.doi.org/10.1002/cncr.27884.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Paochi, P., E. Dossena, A. Iezzi, L. la Pietra, S. Mauri, C. Patroni, and E. Omodeo Salè. "High risk drugsÖ reorganising the European Institute of Oncology." European Journal of Hospital Pharmacy 19, no. 2 (March 12, 2012): 107.1–107. http://dx.doi.org/10.1136/ejhpharm-2012-000074.58.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Arnaut, Daniela. "An Intangible Heritage in Use. Portuguese Institute of Oncology." Modern Lisbon, no. 55 (2016): 16–23. http://dx.doi.org/10.52200/55.a.nk2wyinq.

Full text

Abstract:

The Portuguese Institute of Oncology (IPO) built in modern Lisbon, between 1927 and 1948, and added to until 1996, is the result of the Francisco Gentil effort to study and treat cancer. It is part of the Portuguese modern healthcare network and a reference concerning social, urban and architecture innovations, where the architects Cristino da Silva (1896–1936), Carlos Ramos (1897–1969), Raul Lino (1879–1974), Ernest Koop (1890–1962), Walter Diestel (1904–) and Raul Rodrigues de Lima (1909–1980) took part. By highlighting its cultural value this essay aims to stress the importance of achieving public and institutional awareness, in dealing with its everyday intensive use and transformation, towards a sustainable future.

APA, Harvard, Vancouver, ISO, and other styles

30

Rose, C. M., C. A. Lawton, J. A. Efstathiou, J. E. Bekelman, S. Mutic, C. R. Bogardus, T. R. McNutt, A. L. Zietman, and J. R. Palta. "Developing a National Radiation Oncology Registry (NROR): A Radiation Oncology Institute (ROI) Initiative." International Journal of Radiation Oncology*Biology*Physics 81, no. 2 (October 2011): S693—S694. http://dx.doi.org/10.1016/j.ijrobp.2011.06.1324.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Radhakrishnan, V., V. Vijaykumar, P. Ganesan, R. Rajendranath, G. Trivadi, and S. Tenali. "Bloodstream infections in pediatric patients at cancer institute, Chennai." Indian Journal of Cancer 51, no. 4 (2014): 418. http://dx.doi.org/10.4103/0019-509x.175360.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

De Conno, Franco, Carla Ripamonti, Augusto Caraceni, and Luigi Saita. "Palliative care at the National Cancer Institute of Milan." Supportive Care in Cancer 9, no. 3 (April 4, 2001): 141–47. http://dx.doi.org/10.1007/s005200000219.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Cox, James D. "The Institute of Medicine, The National Cancer Institute, and Clinical Trials." International Journal of Radiation Oncology*Biology*Physics 79, no. 5 (April 2011): 1285–86. http://dx.doi.org/10.1016/j.ijrobp.2011.02.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Catalona, William J., Joan E. Bailey-Wilson, Nicola J. Camp, Stephen J. Chanock, Kathleen A. Cooney, Douglas F. Easton, Rosalind A. Eeles, et al. "National Cancer Institute Prostate Cancer Genetics Workshop." Cancer Research 71, no. 10 (May 15, 2011): 3442–46. http://dx.doi.org/10.1158/0008-5472.can-11-0314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

&NA;. "Diagnostic Cytopathology for Pathologists, 1987 Postgraduate Institute." American Journal of Clinical Oncology 9, no. 6 (December 1986): 544. http://dx.doi.org/10.1097/00000421-198612000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Freund, Karen M., Tracy A. Battaglia, Elizabeth Calhoun, Donald J. Dudley, Kevin Fiscella, Electra Paskett, Peter C. Raich, and Richard G. Roetzheim. "National Cancer Institute Patient Navigation Research Program." Cancer 113, no. 12 (December 15, 2008): 3391–99. http://dx.doi.org/10.1002/cncr.23960.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Knipmeyer, Mary C. "Legislative history of the National Cancer Institute." Cancer 78, no. 12 (December 15, 1996): 2618–19. http://dx.doi.org/10.1002/(sici)1097-0142(19961215)78:12<2618::aid-cncr33>3.0.co;2-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Friedman, Michael A., and Dennis F. Cain. "National cancer institute sponsored cooperative clinical trials." Cancer 65, S10 (May 15, 1990): 2376–82. http://dx.doi.org/10.1002/1097-0142(19900515)65:10+<2376::aid-cncr2820651504>3.0.co;2-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Abrams, Jeffrey, Barry Kramer, James H. Doroshow, and Harold Varmus. "National Cancer Institute–Supported Clinical Trials Networks." Journal of Clinical Oncology 33, no. 3 (January 20, 2015): 293. http://dx.doi.org/10.1200/jco.2014.59.5421.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Mahaney, F. X. "Pittsburgh Cancer Institute: New Clinical Cancer Center." JNCI Journal of the National Cancer Institute 80, no. 12 (August 17, 1988): 894. http://dx.doi.org/10.1093/jnci/80.12.894.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Masnyk, I. J. "International Activities of the National Cancer Institute." JNCI Journal of the National Cancer Institute 80, no. 17 (November 2, 1988): 1366–72. http://dx.doi.org/10.1093/jnci/80.17.1366.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Jacobs-Perkins, A. "Intramural Citations: Which NIH Institute Has More?" JNCI Journal of the National Cancer Institute 82, no. 9 (May 2, 1990): 740–41. http://dx.doi.org/10.1093/jnci/82.9.740.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Chen, Alice P., Mariam Eljanne, Lyndsay Harris, Shakuntala Malik, and Nita L. Seibel. "National Cancer Institute Basket/Umbrella Clinical Trials." Cancer Journal 25, no. 4 (2019): 272–81. http://dx.doi.org/10.1097/ppo.0000000000000389.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Carollo, Angela, Stefano Papi, and Marco Chinol. "Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience." Current Radiopharmaceuticals 9, no. 1 (November 23, 2015): 19–32. http://dx.doi.org/10.2174/1874471008666150313111633.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Kozhukhov, Sergey, Nataliia Dovganych, Ivan Smolanka, and Olga Lyhyrda. "Cardio-oncology in Ukraine: experience at Strazhesko Institute of Cardiology." OncoReview 8, no. 3 (October 20, 2018): 65–69. http://dx.doi.org/10.24292/01.or.120918.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

O'Mara, Ann, and Alexis Bakos. "Preparing Oncology Nurse Scientists: Opportunities at the National Cancer Institute." Oncology Nursing Forum 30, no. 5 (September 1, 2003): 745–46. http://dx.doi.org/10.1188/03.onf.745-746.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Gallo, Tom. "Recapping the 2018 ACCC Institute for the Future of Oncology." Oncology Issues 33, no. 5 (September 3, 2018): 3. http://dx.doi.org/10.1080/10463356.2018.1511097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Krasnoselskyi, M. V., and N. O. Artamonova. "Grigoriev institute for medical radiology and oncology centenary: historic events." Український радіологічний та онкологічний журнал 28, no. 3 (September 25, 2020): 308–25. http://dx.doi.org/10.46879/ukroj.3.2020.308-325.

Full text

Abstract:

Background. The historical survey of the activities carried out at Grigoriev Institute for Medical Radiology and Oncology is of present interest, resulting from the need to structure the Institute development trends in terms of a centenary celebration. Providing insight to visions of the past, one can also apprehend historical events, personalities and phenomena. Purpose – to summarize historical findings on establishing and development of SO «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine». Materials. The study deals with analyzing historical scientific literature, manuscripts, archive paper records, data on electronic data storage devices and other carriers that reveal the historical aspects of forming X-ray Radiography, Radiology and Oncology in Ukraine, particularly in Kharkiv. Results and discussion. For a century of the existence of the Institute, the scientists of several generations have come a long way in forming and developing X-ray Radiography, Radiation Therapy, Diagnostic Radiology, Oncology, Radiobiology, Radiation Dosimetry and others. They were the first to receive radium for the country alongside with establishing oncology dispensaries, X-ray technical school and setting up a chain of remote research and support stations (13 radiology and 26 oncology ones). These days, the team of the Institute are going out of their way to further develop science and medicine to the benefit of human health. Conclusions. One hundred years ago, the first step in developing Oncology and Radiology initiated forming a new scientific community of experts, who contributed a lot to the formation of some frontmost medical science along with non-stop promoting efficacious scientific and theoretical evolvement of those.

APA, Harvard, Vancouver, ISO, and other styles

49

Valvert, Fabiola, and Diana Flores. "Oncology Institute of Guatemala: Experience With NK/T-Cell Lymphomas." Journal of Global Oncology 2, no. 3_suppl (June 2016): 59s. http://dx.doi.org/10.1200/jgo.2016.004341.

Full text

Abstract:

Abstract 24 Background: NK/T-cell nasal type lymphoma is an aggressive non-Hodgkin lymphoma that destroys the palate and nasal anatomy. The incidence in the US and Europe is very low; however, Asia and South America have reported incidence up to 10-15%. This study was done to assess the incidence of this type of lymphoma in our institution, outcomes of treatment efficiency, and to explore demographic, clinical and biological characteristics associated with poor outcomes. Methods: Seventeen NK/T-cell lymphoma patients were diagnosed between 2014-2015, who were treated with radiotherapy plus weekly cisplatin 3-5 doses and consolidation with gemcytabine, oxaliplatin y L-asparaginase 1-4 doses or cisplatin, etopóside, ifosfamide and dexamethasone by 3 doses. Results: The incidence of NK/T-cell lymphoma was 9% of all lymphomas. Median age was 35 years (range: 20-64). The nose is the most frequent location (94.1%,16/17), and 23.5% (4/17) presented with high tumor burden. 100% of these patients presented with palate perforation. One patient presented with stage IV disease. All patients with high tumor burden and stage IV disease died with an overall survival (OS) of 5 months. Three of the deceased were Mayan people (75%). Guatemala's region with the highest incidence was Central (58%) and West (35.3%) vs. North, South and East (5.8%). 65% of the cases were Mayan people vs. 35% of mestizos. All patients had a poor or very poor socio-economic status. Twelve patients achieved complete response (70.6%). After a median follow-up time of 11 months, 1-year event-free survival and OS were 64.7%. Conclusions: The results of this study lead us to the conclusion that Guatemala's indigenous population in the west and center of the country are the most vulnerable population, which include mainly people with a poor socio-economic status. High tumor burden was associated with poor outcomes. Results achieved with radiotherapy plus cisplatin and consolidation with chemotherapy was effective. We recommend the development of educational programs to encourage early diagnosis of this lymphoma in areas of the population that are at risk. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST: Fabiola Valvert Travel, Accommodations, Expenses: Kedrion Biopharma, Asopharma Diana Flores No relationship to disclose

APA, Harvard, Vancouver, ISO, and other styles

50

Ghalleb, Montassar. "Salah Azaiez Institute of Oncology: 50 years of surgical care." International Journal of Gynecologic Cancer 29, no. 7 (May 10, 2019): 1225. http://dx.doi.org/10.1136/ijgc-2019-000447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!